Skip to main content
logo
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.830
+0.085 (3.10%)
Feb 10, 2026, 5:29 PM CET

Oncopeptides AB Revenue

Oncopeptides AB had revenue of 20.21M SEK in the quarter ending September 30, 2025, with 137.62% growth. This brings the company's revenue in the last twelve months to 62.47M, up 130.75% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.

Revenue (ttm)
62.47M
Revenue Growth
+130.75%
P/S Ratio
11.98
Revenue / Employee
832.87K
Employees
75
Market Cap
748.58M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202431.65M-3.57M-10.14%
Dec 31, 202335.22M26.87M321.54%
Dec 31, 20228.36M-109.94M-92.94%
Dec 31, 2021118.30M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioInvent International AB244.85M
Genovis AB (publ.)117.66M
Intervacc AB21.09M
Corline Biomedical AB8.88M
Xspray Pharma AB3.81M
Infant Bacterial Therapeutics AB-1.00K
FluoGuide-703.14K
Mendus AB-1.44M
Revenue Rankings

Oncopeptides AB News

More News